James Boslett - Concepedia

Author

James Boslett

The Ohio State University ORCID

Also Known As

J. Boslett, James Boslett, James J Boslett, James J. Boslett

Publications

972

Citations

H-Index

Concepts

All Affiliations

The Ohio State University The Ohio State University Wexner Medical Center University of Pittsburgh Mayo Clinic WinnMed

About

James Boslett is an author at The Ohio State University specializing in medicine, immunology, and cardiovascular disease.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	457
2	Immunology	2	2	102
3	Health Sciences	1	1	355
4	Biochemistry	1	1	64
5	Cell Biology	1	1	355

James Boslett

Publications

955

Citations

H-Index

Page 1

	Year	Citations
A Potent and Specific CD38 Inhibitor Ameliorates Age-Related Metabolic Dysfunction by Reversing Tissue NAD+ Decline Mariana G. Tarragó, Claudia C.S. Chini, Karina S. Kanamori, Cell Metabolism Lifespan ExtensionMetabolic SyndromeAgingLongevityMedicine	2018	355
SARS-CoV-2 growth, furin-cleavage-site adaptation and neutralization using serum from acutely infected hospitalized COVID-19 patients William B. Klimstra, Natasha L. Tilston‐Lunel, Sham Nambulli, Journal of General Virology	2020	153
Cytoglobin regulates blood pressure and vascular tone through nitric oxide metabolism in the vascular wall Xiaoping Liu, Mohamed A. El‐Mahdy, James Boslett, Nature Communications	2017	100
Luteolinidin Protects the Postischemic Heart through CD38 Inhibition with Preservation of NAD(P)(H) James Boslett, Craig Hemann, Yong Zhao, Journal of Pharmacology and Experimental Therapeutics	2017	68
Depletion of NADP(H) due to CD38 activation triggers endothelial dysfunction in the postischemic heart Levy Reyes, James Boslett, Saradhadevi Varadharaj, Proceedings of the National Academy of Sciences Vascular DiseaseImmunologyCardiovascular FunctionRedox BiologyOxidative Stress	2015	64
Characterization of CD38 in the major cell types of the heart: endothelial cells highly express CD38 with activation by hypoxia-reoxygenation triggering NAD(P)H depletion James Boslett, Craig Hemann, Fedias L. Christofi, American Journal of Physiology-Cell Physiology	2017	57
Inhibition of CD38 with the Thiazoloquin(az)olin(on)e 78c Protects the Heart against Postischemic Injury James Boslett, Nikhil Reddy, Yasmin A. Alzarie, Journal of Pharmacology and Experimental Therapeutics	2019	39
Genetic deletion of CD38 confers post-ischemic myocardial protection through preserved pyridine nucleotides James Boslett, Moustafa Helal, Eduardo N. Chini, Journal of Molecular and Cellular Cardiology CardiomyopathyCardiovascular DiseaseGenetic DeletionImmunologyMolecular Biology	2018	38
SARS-CoV-2 growth, furin-cleavage-site adaptation and neutralization using serum from acutely infected, hospitalized COVID-19 patients William B. Klimstra, Natasha L. Tilston‐Lunel, Sham Nambulli,	2020	26
Insulin‐like growth factor 1 prevents diastolic and systolic dysfunction associated with cardiomyopathy and preserves adrenergic sensitivity Steve Roof, James Boslett, Duncan Russell, Acta Physiologica	2015	19

Page 1